It's a dual-benefit scenario
With respect to the newness criterion at 419.66(b)(1), the aprevo Cervical ACDF System received FDA Breakthrough Device designation effective September 15, 2023, under the name aprevo-C cervical interbody fusion device
The increase in appetite for obesity drugs, Global Sachs Research
The key reason acetic acid can help is that peptide solubility is influenced by charge and pH
OMahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, et al
TRANSFORMING GROWTH FACTOR (TGF): Promotes angiogenesis, which is the physiological process involving the growth of new blood vessels which carry oxygen and various other nutrients to the cells